Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients

Yu-Ling Hsu,Mu-Shiang Huang,Hsien-Yuan Chang,Cheng-Han Lee,Dao-Peng Chen,Yi-Heng Li,Ting-Hsin Chao,Yen-Wen Liu,Ping-Yen Liu
DOI: https://doi.org/10.1186/s12877-023-04103-w
IF: 4.07
2023-07-20
BMC Geriatrics
Abstract:The second-and third-generation drug-eluting stents (DESs) in-stent restenosis (ISR) genetic risk score (GRS) model has been previously validated. However, the model has not been validated in geriatric patients. Therefore, we conducted this study to test the feasibility of the DES-ISR GRS model in geriatric patients with coronary artery disease (CAD) in Taiwan.
geriatrics & gerontology,gerontology
What problem does this paper attempt to address?